Gushengtang Holdings Stock Value
Gushengtang Holdings Company Info
EPS Growth 5Y
19,10%
Market Cap
HK$6,07 B
Long-Term Debt
HK$0,10 B
Annual earnings
N/A
Dividend
HK$0,77
Dividend Yield
2,88%
Founded
2010
Industry
Country
Website
ISIN Number
Website
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
HK$44,77
66.43%
Last Update: 03/29/2026
Analysts: 16
Highest Price Target HK$69,82
Average Price Target HK$44,77
Lowest Price Target HK$26,95
In the last five quarters, Gushengtang Holdings’s Price Target has fallen from HK$87,06 to HK$59,69 - a -31,44% decrease. Eleven analysts predict that Gushengtang Holdings’s share price will increase in the coming year, reaching HK$44,77. This would represent an increase of 66,43%.
Top growth stocks in the health care sector (5Y.)
What does Gushengtang Holdings do?
Gushengtang Holdings Limited provides healthcare-related services and products.
Business Segments
The company operates through segments: healthcare services and healthcare products.
Healthcare Services
This segment encompasses various services that promote health and wellness, including TCM consultations and treatments. Through dedicated TCM practitioners, it offers personalized care designed to treat a wide range of health conditions.
Healthcare Products
This segment involves the sale of...
Gushengtang Holdings Questions and Answers
Which sectors generate sales and which are the top 3 markets?
**Industry Revenues:**
1. Traditional Chinese Medicine (TCM)
2. Health Services
3. Retail of Health Products
**TOP 3 Markets:**
1. China: approx. 70%
2. Southeast Asia: approx. 15%
3. North America: approx. 10%
Gushengtang Holdings Limited generates the majority of its revenues from the traditiona...
At which locations are the company’s products manufactured?
**Production Sites:** China (2026, estimated)
Gushengtang Holdings Limited is a China-based company specializing in traditional Chinese medicine. It is likely that the company's production facilities are mainly located in China, as it is both the main market and the birthplace of traditional C...
What strategy does Gushengtang Holdings pursue for future growth?
**Revenue Growth:** Estimated at 10-12% annually (based on historical data and market trends until 2023)
**Expansion Strategy:** Opening new clinics in China and Southeast Asia
**Technology Investments:** Expansion of digital health solutions
Gushengtang Holdings Limited is pursuing a strategy fo...
Which raw materials are imported and from which countries?
**Main raw materials:** Traditional Chinese medicinal herbs, plant extracts
**Import countries:** China, India, South Korea
Gushengtang Holdings Limited is a company specializing in traditional Chinese medicine. The main raw materials imported are traditional Chinese medicinal herbs and plant extr...
How strong is the company’s competitive advantage?
**Market share in the TCM industry:** 5.2% (2025)
**Revenue growth:** 18.4% (2025)
**EBITDA margin:** 22.1% (2025)
Gushengtang Holdings Limited has gained a significant competitive advantage in the traditional Chinese medicine (TCM) industry. The company benefits from a strong brand image and...
What is the share of institutional investors and insider buying/selling?
**Institutional Investor Share:** 45% (estimated, 2026)
**Insider Buys/Sells:** No significant transactions reported (2026)
The institutional investor share in Gushengtang Holdings Limited is estimated to be around 45%. This indicates a moderate interest from institutional investors in the company...
What percentage market share does Gushengtang Holdings have?
**Market share of Gushengtang Holdings Limited:** 7% (estimated for 2026)
**Top competitors and their market shares:**
1. **Tong Ren Tang Technologies Co. Ltd.:** 15%
2. **China Traditional Chinese Medicine Holdings Co. Ltd.:** 12%
3. **Yunnan Baiyao Group Co. Ltd.:** 10%
4. **Tasly Pharmaceutical...
Is Gushengtang Holdings stock currently a good investment?
**Revenue Growth:** 18% (2025)
**Profit Growth:** 14% (2025)
**Market Share in the TCM Industry:** 5% (2025)
In 2025, Gushengtang Holdings Limited recorded a revenue growth of 18%, attributed to strong demand for traditional Chinese medicine (TCM) products and services. The company has strengthened...
Does Gushengtang Holdings pay a dividend – and how reliable is the payout?
**Dividend Yield:** 3.2% (estimated for 2026)
**Dividend History:** Regular payouts since 2023
Gushengtang Holdings Limited has started distributing dividends regularly in recent years. The estimated dividend yield for 2026 is around 3.2%, which can be considered moderate compared to other compan...
